Professional Documents
Culture Documents
Figure 1: Beam geometry of the left and right lateral brain and c-spine fields
Figure 2: Right and left lateral brain and c-spine fields
I used a field in field technique to generate a plan that met the target coverage constraints
while also minimizing the dose to the OAR and reducing the areas of 105%. The target coverage
goal was at least 95% of the target receiving 100% of the prescription dose. After I was satisfied
with the coverage and overall dose distribution, I created the feathered dose gradient at the
inferior portion of the plan. The gradient is achieved by adding additional field in field segments
to close one MLC leaf at a time for a total length of 6 cm from both the left and right lateral
fields. Figure 3 below demonstrates 4 of the multiple field in field segments used to create the
dose gradient.
Figure 3: Example of the field in field segments used to create the dose distribution at the
inferior portion of the brain and cervical spine plan.
1. 2.
3. 4.
Once the field in field segments were created, I divided the weighting of the original left and
right lateral parent fields and redistributed it evenly to each field in field segment. In this specific
case, the left lateral parent field was originally weighted 0.471. There was a total of 6 field in
field segments created from the left lateral field when creating the dose gradient. Therefore,
0.471 was divided by 7 to account for each segment and the main left lateral field. Each of the
field weight was changed to be 0.067. The same process was repeated for the right lateral field
resulting in an even dose gradient (figure 4).
Figure 4: Dose gradient at inferior portion of brain and cervical spine plan.
I used the dose profile tool to ensure the area of the dose gradient had the proper dose falloff
(figure 5). Ideally, the dose profile will resemble a 45° angle when measuring from the inferior
prescription isodose line to the inferior field edge.
Figure 12: Initial coverage of lower “false” spine plan with 95% (green) covering the most
anterior portion of the PTV (magenta).
After obtaining adequate coverage on the lower “false” spine field, I created another dose
gradient at the superior edge of the field where the lower spine fields and upper spine fields
overlap. The dose gradient was produced in the same fashion as done previously. That is,
multiple field in field segments were created, closing one leaf at a time for a total length of 12
cm. The MLC leaves were closed starting with the most superior leaf on the lower “false” spine
field and working inferiorly for the entire 12 cm area of overlap (figure 12).
Figure 12: Demonstrates 4 of the 18 total FIF segments used to create a dose gradient on the
superior aspect of the lower “false” spine field.
1. 2.
3. 4.
After creating the field in field segments, the initial weighting of the single posterior field
used in the plan was redistributed evenly to each of the segments. This creates a smooth dose
gradient at the junction of the upper and lower spine fields. The dose profile tool was again used
to confirm this process was successful. If done properly, the dose profile will result in a 45°
angle as shown in figure 13.
Figure 13: Dose gradient on the superior portion of the lower “false” spine plan
Optimization
Upper Spine Plan
At this point, I have created a finished plan that encompasses the brain and cervical spine.
Additionally, I have setup the fields on the upper spine plan, lower “false” spine plan, and the
lower “true” spine plan. Next, I moved on to optimizing on the upper spine. Prior to entering the
optimizer, I created a plan sum that combined the Brain&Cspine and lower “false” spine plans to
use as a base plan (figure 16). I also created 2 target optimization structures. The z_PTVOpt
Upper structure consisted of the PTV_spine extending from the area of the C-spine dose gradient
and continues inferiorly into the lower spine dose gradient (figure 17). Similarly, the z_PTVOpt
Lower structure consisted of the PTV_Spine structure within the lower spine fields and extends
into overlap between the upper and lower spine fields (figure 18). Finally, I created 2 dose
limiting annulus (DLA) structures that functioned to help conform the dose. The zDLA upper
and zDLA lower structures are created by expanding the upper and lower z_PTVOpt structures
by 2 cm, respectively, and then cropping it away by 0.2 cm (figure 18).
Figure 16: Plan sum of the Brain&Cspine and Lower “false” spine fields that is used as a base
plan during optimization of the upper spine plan.
Figure 17: z_PTVOpt Upper structure used for optimization of the upper spine plan.
Figure 18: z_PTVOpt Upper structure used for optimization of the lower spine plan.
Figure 19: zDLA upper (green) and zDLA lower (red) optimization structures. zPTVOpt upper
(blue), zPTVOpt lower (orange).
Upon entering the optimizer, I selected the Brain&Cspine and Lower “false” spine plan
sum as the base plan and selected the fixed jaws option under the plan information tab. (figures
20-21).
Next, I added upper and lower objectives on the z_PTVOpt Upper structure, upper
constraints on both kidneys, and an upper constraint on the zDLA Upper structure (figure 22).
After the first optimization, I created additional structures to fill in areas that were lacking
prescription coverage and to reduce areas of 105%. Once I was satisfied with the dose
distribution of the Brain&Cspine plan combined with the upper spine plan, I moved on to the
lower “true” spine plan.
Figure 23: Plan sum of the Brain&Cspine and Upper Spine plan that was used as a base plan in
the optimization of the lower “true” spine plan.
Figure 24: Optimization objectives used for the lower “true” spine plan
Plan Evaluation
Although I was happy with the overall dose distribution, I hoped to be able to increase
the uniformity of the 100% isodose line in the areas where 2 plans overlap. Normalization isn’t
always standardly used at my clinical site to achieve target coverage. However, I chose to utilize
volumetric normalization on the upper spine and lower “true” spine plan” to visually smooth out
100% isodose line in the areas that 2 plans overlapped. The upper spine plan used a plan
normalization of 97.5%. This means the dose on the upper spine plan was increased by 2.5%.
Likewise, the lower “true” spine plan was assigned a plan normalization value of 98.3%,
resulting in the overall total dose increased by 1.7%. The Brain&Cspine plan was not
normalized. After visually assessing the dose distribution of the total plan sum consisting of all 3
plans, I exported the plan into the ProKnow software (figure 25). Overall, I was pleased with the
target coverage and acceptable amounts of 105%. An area of cooler coverage was seen in the
Brain&Cspine plan due to intentional MLC blocking to spare the optic structures (figure 26).
The maximum global hot spot in the plan was 3958.8 cGy. This is considered acceptable as it
was located on the edge of the PTV and was less than 110% (figure 27). When comparing the
ProKnow score card to the results calculated in Eclipse, I noticed some discrepancies. This is a
known issue between ProKnow and the Eclipse TPS in which the dose metrics can vary widely
due to the voxelization method used. The inconsistencies of the dose metrics between my plan
and ProKnow are included in table 1 and figure 28 below. One metric I did not meet was the
mean dose for the right kidney. If I were to complete this plan again, perhaps I could try a
different posterior oblique angle to avoid exit dose into the right kidney from the left posterior
oblique beam. Figures 30 and 31 below displays the final dose distribution of my treatment plan
as well as the final dose volume histogram. As medical dosimetrists, we often encounter
circumstances in which we must evaluate the cost versus benefit in our planning decisions. Each
treatment plan and the available treatment techniques has its own benefits. There are many
tradeoffs in the field of medical dosimetry that are inevitable when generating the best treatment
plan for the patient.
Figure 28: Maximum and mean doses achieved in the Eclipse TPS.
Figure 25: ProKnow Score Sheet.
Figure 26: Area of cool prescription coverage in the Brain&Cspine plan in order to spare optic
structures. PTV (magenta), Right optic nerve (yellow), Right lens (lime green), Left optic nerve
(purple), Left lens (orange).
Figure 27: Maximum global hot spot in the plan.